ÌÇÐÄÊÓƵ

Email

Positions

Assistant Professor

Center for Gene Therapy
ÌÇÐÄÊÓƵ of Medicine
Houston, TX, US

Professional Interests

Websites

Selected Publications

• Mejia J, Salisbury E, Sonnet C, Gugala Z, Olmsted-Davis EA, Davis AR.. " " Stem Cells Transl. Medicine. 2021 Apr 10; 4 : 623-635.
  Pubmed PMID: .
• Dickerson A, Davis EL, Sonnet C, Davis AR, Olmsted-Davis EA.. " " Methods Mol Biol.. 2019 ; 19-28.
  Pubmed PMID: .
• Alvarez-Urena P, Zhu B, Henslee G, Sonnet C, Davis E, Sevick-Muraca E, Davis A, Olmsted-Davis E.. " " J Cell Biochem.. 2017 ; 3627-3634.
  Pubmed PMID: .
• Olmsted-Davis EA, Salisbury EA, Hoang D, Davis EL, Lazard Z, Sonnet C, Davis TA, Forsberg JA, Davis AR.. " " Stem Cells Transl Med.. 2017 ; 1109-1119.
  Pubmed PMID: .
• Alvarez-Urena P, Davis E, Sonnet C, Henslee G, Gugala Z, Strecker EV, Linscheid LJ, Cuchiara M, West J, Davis A, Olmsted-Davis E.. " " Tissue Eng Part A.. 2017 ; 177-184.
  Pubmed PMID: .
• Davis EL, Sonnet C, Lazard ZW, Henslee G, Gugala Z, Salisbury EA, Strecker EV, Davis TA, Forsberg JA, Davis AR, Olmsted-Davis EA.. " " J Orthop Res. 2016 ; 1894-1904.
  Pubmed PMID: .
• Lazard ZW, Olmsted-Davis EA, Salisbury EA, Gugala Z, Sonnet C, Davis EL, Beal E 2nd, Ubogu EE, Davis AR. " " Clin Orthop Relat Res.. 2015 Sep ; 473 (9) : 2790-806.
  Pubmed PMID: .
• Sonnet C, Simpson CL, Olabisi RM, Sullivan K, Lazard Z, Gugala Z, Peroni JF, Weh JM, Davis AR, West JL, Olmsted-Davis EA.. " Rapid healing of femoral defects in rats with low dose Corinne Sonnet Page 5 of 5 sustained BMP2 expression from PEGDA hydrogel microspheres.. " J Orthop Res. 2013 ; 1597-1604.
• Créange A, Chazaud B, Plonquet A, Sharshar T, Poron F, Sonnet C, Raphaël JC, Gherardi RK.. " " Neurology. 2001 Nov 13; 57 (9) : 1704-6.
  Pubmed PMID: .

Projects

Co-Director

Gene Vector Core (GVC) (11/2021 - present)

ÌÇÐÄÊÓƵ of Medicine / Advanced Technology Cores

The Gene Vector Core provides services for viral-vector packaging, viral titers, plasmid cloning and plasmid preparation. The service is open to all domestic and international institutions. Of the available gene delivery systems, virally derived vectors are among the most efficacious due to their retention of traits preserved during natural selection. We produce and purify viral vectors including Adeno-Associated Virus (AAV), First Generation Adenovirus (Ad), Helper-Dependent Adenovirus (HDAd), Lentivirus (LV), Retrovirus (RV) and G-deleted Rabies Virus (RaV). With the use of cutting-edge technologies, we strive to provide high quality products at competitive prices. For more information, visit the Gene Vector website at bcm.edu/research/atc-core-labs/gene-vector-core

Director of Production

Vector Development Laboratory (VDL) (12/2012 - 10/2021)

ÌÇÐÄÊÓƵ of Medicine

Gene transfer vectors provide investigators important research tools in studies of gene function. The Vector Development Laboratory (VDL) operates as a non-profit core facility and functions as a preclinical service and GLP manufacturing facility for gene therapy vectors. The VDL provides comprehensive service in the design, creation, production, and analysis of standard gene therapy. For more information, please visit our website at bcm.edu/vector